BRONCHIAL ASTHMA IN CHILDREN: A CALL FOR ACTION IN DEVELOPING COUNTRIES
DOI:
https://doi.org/10.52754/16948831_2024_2(4)_6Keywords:
bronchial asthma, developing countries, healthcare access, environmental triggers, childhood asthma, asthma diagnosisAbstract
In underdeveloped nations where low resources and poor healthcare infrastructure impede accurate diagnosis and therapy, bronchial asthma in children is a significant public health issue. Children's health and quality of life are seriously threatened by this disorder, which is marked by coughing, dyspnea, and repeated wheezing, particularly when combined with environmental elements such pollution and poor air quality. Targeted treatments are desperately needed, as early childhood onset and a high frequency in socioeconomically poor areas highlight. Emphasizing the requirement of easily available diagnostic equipment, better treatment choices, and community education, this analysis exposes the crucial deficiencies in asthma therapy in poor countries. Reducing the burden of childhood asthma and enhancing the outcomes for impacted children depend on more investment in healthcare and greater emphasis on asthma-specific public health projects.
References
T. D, G. E, P. M, G. G, and K. G, “The effect of manual therapy on diaphragm function in adults with asthma: Protocol for a randomized controlled trial,” F1000Research, vol. 12, Mar. 2024, doi: 10.12688/f1000research.141455.2.
T. M, G. Jr, H. M, L. S, and H. Pj, “6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records,” Lancet Psychiatry, vol. 8, no. 5, May 2021, doi: 10.1016/S2215-0366(21)00084-5.
G. A. Roth et al., “Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015,” J. Am. Coll. Cardiol., vol. 70, no. 1, pp. 1–25, Jul. 2017, doi: 10.1016/j.jacc.2017.04.052.
C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” The Lancet, vol. 395, no. 10223, pp. 497–506, Feb. 2020, doi: 10.1016/S0140-6736(20)30183-5.
V. Bosch Castells et al., “Pediatric Respiratory Hospitalizations in the Pre-COVID-19 Era: The Contribution of Viral Pathogens and Comorbidities to Clinical Outcomes, Valencia, Spain,” Viruses, vol. 16, no. 10, p. 1519, Sep. 2024, doi: 10.3390/v16101519.
E. M. Mirrakhimov et al., “The association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (Central Asian nation) population,” BMC Res. Notes, vol. 7, p. 411, Jun. 2014, doi: 10.1186/1756-0500-7-411.
K. Y et al., “Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice,” Antivir. Chem. Chemother., vol. 20, no. 4, Mar. 2010, doi: 10.3851/IMP1477.
L. Lupi, A. Vitiello, C. Parolin, A. Calistri, and A. Garzino-Demo, “The Potential Role of Viral Persistence in the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC),” Pathog. Basel Switz., vol. 13, no. 5, p. 388, May 2024, doi: 10.3390/pathogens13050388.
T. D. Rozen, “Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian/Asiatic flu,” Cephalalgia, vol. 40, no. 13, pp. 1406–1409, Nov. 2020, doi: 10.1177/0333102420965132.
Факторы, влияющие на риск развития бронхиальной астмы у детей в Кыргызской Республике / Ш. А. Сулайманов, М. Б. Жуманалиева, Ж. К. Муратова, А. Ш. Сулайманова // Вестник Ошского государственного университета. – 2020. – № 2-5. – С. 79-85. – EDN ZHZLAB.
Динамика заболеваемости болезнями органов дыхания среди населения Ошской области по данным ОМОКБ / А. А. Алибаева, Ф. Т. Рысматова, Г. О. Омаралиева [и др.] // Вестник Ошского государственного университета. – 2024. – № 2. – С. 21-30. – DOI 10.52754/16948610_2024_2_3. – EDN IDCQKR.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Osh State University. Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
